Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - BARRIS PETER J
Last Updated 
22-Jul-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BARRIS PETER J: Declared Holdings
Company/RelationshipReportedShares  Ownership
Adaptimmune Therapeutics plc
Beneficial Owner (10% or more)
NasdaqGS:ADAP
(historical quotes, profile, other insiders)
1-Jan-1659,269,000  Indirect
Achaogen, Inc.
Beneficial Owner (10% or more)
NasdaqGM:AKAO
(historical quotes, profile, other insiders)
3-Jun-164,715,128  Indirect
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
18-Jul-1614,084,162  Indirect
AVEO Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:AVEO
(historical quotes, profile, other insiders)
13-May-1610,362,694  Indirect
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
CVENT, INC. Common Stock
Beneficial Owner (10% or more)
NYSE:CVT
(historical quotes, profile, other insiders)
25-Nov-143,997,905  Indirect
Tableau Software, Inc. Class A
Beneficial Owner (10% or more)
NYSE:DATA
(historical quotes, profile, other insiders)
2-Dec-14140,821  Indirect
Dermira, Inc.
Beneficial Owner (10% or more)
NasdaqGS:DERM
(historical quotes, profile, other insiders)
8-Oct-143,502,922  Indirect
Epizyme, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EPZM
(historical quotes, profile, other insiders)
12-Jan-166,261,599  Indirect
GlycoMimetics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:GLYC
(historical quotes, profile, other insiders)
16-Nov-158,584,128  Indirect
Groupon, Inc.
Director
NasdaqGS:GRPN
(historical quotes, profile, other insiders)
8-Jun-16
10-Jun-16
116,923
   33,203,459
33,320,382
  Direct
  Indirect  
  Total
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
23-Dec-1435,298,087  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,789,420  Indirect
Mirna Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:MIRN
(historical quotes, profile, other insiders)
6-Oct-152,971,517  Indirect
Senseonics Holdings, Inc. Commo
Beneficial Owner (10% or more)
NYSE MKT:SENS
(historical quotes, profile, other insiders)
23-Mar-1626,330,980  Indirect
Sunesis Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqCM:SNSS
(historical quotes, profile, other insiders)
29-Aug-144,659,333  Indirect
Supernus Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:SUPN
(historical quotes, profile, other insiders)
11-Nov-154,203,312  Indirect
TRACON Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:TCON
(historical quotes, profile, other insiders)
4-Feb-151,888,474  Indirect
TESARO, Inc.
Beneficial Owner (10% or more)
NasdaqGS:TSRO
(historical quotes, profile, other insiders)
18-Mar-1610,276,647  Indirect
Vitae Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:VTAE
(historical quotes, profile, other insiders)
1-Jul-151,789,352  Indirect
Xtera Communications, Inc.
Beneficial Owner (10% or more)
NasdaqGM:XCOM
(historical quotes, profile, other insiders)
17-Nov-153,631,537  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
18-Jul-16 *2,290,951ARDX Purchase at $8.73 per share.
(Cost of $20,000,002)
10-Jun-16 *358,382GRPN Sale at $3.20 per share.
(Proceeds of $1,146,822)
9-Jun-16 *281,663GRPN Sale at $3.26 per share.
(Proceeds of $918,221)
8-Jun-16 *4,189,110GRPN Acquisition (Non Open Market) at $0 per share.
8-Jun-16 *14,377,000GRPN Disposition (Non Open Market) at $0 per share.
8-Jun-16 45,991GRPN Acquisition (Non Open Market) at $0 per share.
3-Jun-16 *4,715,128AKAO Statement of Ownership
13-May-16 *10,362,694AVEO Statement of Ownership
23-Mar-16 *2,631,578SENS Purchase at $2.85 - $2.85 per share.
(Cost of about $7,500,000)
18-Mar-16 *1,420,858TSRO Purchase at $35.19 - $35.19 per share.
(Cost of about $50,000,000)
17-Mar-16 *23,699,402SENS Statement of Ownership
13-Jan-16 *1,500,000ARDX Purchase at $10 per share.
(Cost of $15,000,000)
12-Jan-16 *1,111,111EPZM Purchase at $9 - $9 per share.
(Cost of about $10,000,000)
1-Jan-16 *59,269,000ADAP Statement of Ownership
17-Nov-15 *800,000XCOM Purchase at $5 - $5 per share.
(Cost of about $4,000,000)
17-Nov-15 *2,797,219XCOM Acquisition (Non Open Market)
16-Nov-15 *452GLYC Sale at $6.91 - $6.91 per share.
(Proceeds of about $3,123)
16-Nov-15 *9,445GLYC Option Exercise at $0.33 - $0.33 per share.
(Cost of about $3,116)
12-Nov-15 *34,318XCOM Statement of Ownership
11-Nov-15 *1,480,814SUPN Acquisition (Non Open Market) at $0 per share.
11-Nov-15 *4,993,557SUPN Disposition (Non Open Market) at $0 per share.
6-Oct-15 *857,142MIRN Purchase at $7 - $7 per share.
(Cost of about $6,000,000)
6-Oct-15 *289,166MIRN Acquisition (Non Open Market) at $0 per share.
5-Oct-15 *1,825,209MIRN Acquisition (Non Open Market)
1-Jul-15 *11,038VTAE Acquisition (Non Open Market) at $0 per share.
1-Jul-15 *833,250VTAE Disposition (Non Open Market) at $0 per share.
18-Jun-15 28,889GRPN Acquisition (Non Open Market) at $0 per share.
17-Jun-15 *111,881SUPN Sale at $16.02 - $16.67 per share.
(Proceeds of about $1,829,000)
16-Jun-15 *55,105SUPN Sale at $16.85 - $16.85 per share.
(Proceeds of about $929,000)
15-Jun-15 *3,921,000SUPN Disposition (Non Open Market) at $0 per share.
15-Jun-15 *1,162,791SUPN Acquisition (Non Open Market) at $0 per share.
5-Jun-15 *4,672,897ARDX Purchase at $10.70 - $10.7 per share.
(Cost of about $50,000,000)
2-Jun-15 *2,129TSRO Sale at $57.55 - $58.13 per share.
(Proceeds of about $123,000)
1-Jun-15 *1,010,000TSRO Disposition (Non Open Market) at $0 per share.
1-Jun-15 *12,709TSRO Acquisition (Non Open Market) at $0 per share.
4-Feb-15 *500,000TCON Purchase at $10 - $10 per share.
(Cost of about $5,000,000)
4-Feb-15 *1,388,474TCON Acquisition (Non Open Market)
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
22-Jan-15 *162,780BOX Statement of Ownership
26-Dec-14 *1,972ARDX Sale at $21.28 - $21.28 per share.
(Proceeds of about $42,000)
23-Dec-14 *19,868,965ILIU Purchase at $0.10 - $0.1 per share.
(Cost of about $1,987,000)
23-Dec-14 *10,000ARDX Disposition (Non Open Market) at $0 per share.
23-Dec-14 *2,552ARDX Acquisition (Non Open Market) at $0 per share.
5-Dec-14 *129,297GRPN Acquisition (Non Open Market) at $0 per share.
5-Dec-14 *10,302,000GRPN Disposition (Non Open Market) at $0 per share.
2-Dec-14 *1,633,750DATA Disposition (Non Open Market) at $0 per share.
2-Dec-14 *1,734,494DATA Acquisition (Non Open Market) at $0 per share.
25-Nov-14 *1,010,000CVT Disposition (Non Open Market) at $0 per share.
25-Nov-14 *13,219CVT Acquisition (Non Open Market) at $0 per share.
8-Oct-14 *3,416,569DERM Acquisition (Non Open Market) at $0 per share.
8-Oct-14 *69,112DERM Purchase at $16 - $16 per share.
(Cost of about $1,106,000)
2-Oct-14 *17,241DERM Statement of Ownership
29-Aug-14 *11,600SNSS Sale at $7.51 - $7.51 per share.
(Proceeds of about $87,000)
28-Aug-14 *146,800SNSS Sale at $7.87 - $7.87 per share.
(Proceeds of about $1,155,000)
27-Aug-14 *108,300SNSS Sale at $8.17 - $8.17 per share.
(Proceeds of about $885,000)
25-Aug-14 *7,099DATA Sale at $60.40 - $60.4 per share.
(Proceeds of about $429,000)
22-Aug-14 *52,312DATA Sale at $60.46 - $61.02 per share.
(Proceeds of about $3,177,000)
21-Aug-14 *30,000DATA Sale at $59.19 - $59.79 per share.
(Proceeds of about $1,785,000)
20-Aug-14 *2,229,962DATA Acquisition (Non Open Market) at $0 per share.
20-Aug-14 *2,100,474DATA Disposition (Non Open Market) at $0 per share.
15-Aug-14 *2,641CVT Sale at $26.19 - $26.19 per share.
(Proceeds of about $69,000)
15-Aug-14 *3,411EPZM Sale at $36.45 - $36.94 per share.
(Proceeds of about $125,000)
14-Aug-14 *1,302,900EPZM Disposition (Non Open Market) at $0 per share.
14-Aug-14 *17,059EPZM Acquisition (Non Open Market) at $0 per share.
14-Aug-14 *13,221CVT Acquisition (Non Open Market) at $0 per share.
14-Aug-14 *1,010,000CVT Disposition (Non Open Market) at $0 per share.
12-Aug-14 *35,540SNSS Sale at $6.76 - $6.76 per share.
(Proceeds of about $240,000)
8-Aug-14 *675,000SNSS Sale at $6.62 - $6.62 per share.
(Proceeds of about $4,469,000)
6-Aug-14 *230,769LOXO Purchase at $13 - $13 per share.
(Cost of about $3,000,000)
6-Aug-14 *1,558,651LOXO Acquisition (Non Open Market)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?